Mice Model Market - Global Forecast to 2029

by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery)

Published	Pages	Publisher	Report code
Feb 2024	369	MarketsandMarkets	ASDR-657785

Published: Feb 2024 - Pages : 369 - Publisher : MarketsandMarkets - Report code : ASDR-657785

Table of Content

1 INTRODUCTION (Page No. - 51)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS & EXCLUSIONS

1.3 MARKET SCOPE

1.3.1 MARKET SEGMENTATION

1.3.2 REGIONS COVERED

1.4 YEARS CONSIDERED

1.5 CURRENCY CONSIDERED

1.6 STAKEHOLDERS

1.7 LIMITATIONS

1.8 SUMMARY OF CHANGES

1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 57)

2.1 RESEARCH DATA

FIGURE 1 RESEARCH DESIGN

2.1.1 SECONDARY DATA

2.1.2 PRIMARY DATA

FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES

2.2 MARKET ESTIMATION METHODOLOGY

FIGURE 3 MICE MODEL INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023

2.2.1 BOTTOM-UP APPROACH

FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023

FIGURE 5 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2023)

2.2.2 INSIGHTS FROM PRIMARY EXPERTS

FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES

2.3 TOP-DOWN APPROACH

FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH

2.4 GROWTH FORECAST

FIGURE 8 MARKET: CAGR PROJECTIONS

2.5 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 9 DATA TRIANGULATION METHODOLOGY

2.6 RESEARCH ASSUMPTIONS

2.7 MARKET FORECAST

TABLE 1 FACTOR ANALYSIS

2.8 RISK ANALYSIS

2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 68)

FIGURE 10 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2024 VS. 2029 (USD MILLION)

FIGURE 11 MICE MODEL INDUSTRY, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)

FIGURE 12 MARKET, BY THERAPEUTIC AREA, 2024 VS. 2029 (USD MILLION)

FIGURE 13 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)

FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 72)

4.1 MICE MODEL MARKET OVERVIEW

FIGURE 15 RISING INVESTMENTS AND ADVANCEMENTS IN MOUSE MODEL TECHNOLOGY TO DRIVE MARKET GROWTH

4.2 ASIA PACIFIC: MARKET, BY MODEL TYPE & SERVICE (2023)

FIGURE 16 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023

4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

4.4 MARKET SHARE, BY END USER

FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 75)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 19 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

TABLE 2 MICE MODEL INDUSTRY: IMPACT ANALYSIS

5.2.1 DRIVERS

5.2.1.1 High adoption of mice models in preclinical studies

5.2.1.2 Increasing demand for mouse clinical trials (MCTs)

5.2.1.3 Growing preference for personalized medicine in oncology

5.2.1.4 Advancements in genetic engineering

5.2.2 RESTRAINTS

5.2.2.1 Introduction of 3D printed models

5.2.2.2 Ethical concerns and regulatory restrictions

5.2.3 OPPORTUNITIES

5.2.3.1 Utilization of CRISPR in biomedical research

5.2.3.2 Rising demand for disease-specific models

5.2.4 CHALLENGES

5.2.4.1 Development of alternative animal testing methods

5.2.4.2 Genetic & Phenotypic variability

5.3 MARKET LANDSCAPE

5.3.1 HISTORY OF MICE MODELS

5.3.2 MICE MODEL GENERATION PROCESS

5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT

5.3.4 TECHNOLOGICAL ADVANCEMENTS

5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT

5.4 SUPPLY CHAIN ANALYSIS

FIGURE 20 MARKET: SUPPLY CHAIN ANALYSIS

5.5 VALUE CHAIN ANALYSIS

FIGURE 21 MARKET: VALUE CHAIN ANALYSIS

5.6 PRICING ANALYSIS

TABLE 3 AVERAGE SELLING PRICE TREND OF MODEL TYPE, BY KEY PLAYER

5.6.1 AVERAGE SELLING PRICE TREND ANALYSIS

5.7 ECOSYSTEM ANALYSIS

FIGURE 22 MARKET: ECOSYSTEM ANALYSIS

5.7.1 MICE MODEL VENDORS

TABLE 4 MARKET: ROLE IN ECOSYSTEM, BY MICE MODEL VENDORS

5.7.2 MICE MODEL SERVICE VENDORS

TABLE 5 MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR

5.7.3 MICE MODEL END USERS

TABLE 6 MARKET: ROLE IN ECOSYSTEM, BY END USER

5.7.4 REGULATORY ORGANIZATIONS

TABLE 7 MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION

5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.9 PATENT ANALYSIS

5.9.1 METHODOLOGY

5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024

TABLE 8 PATENTS FILED (2014−2024)

5.9.3 INNOVATION & PATENT APPLICATIONS

FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED (2014−2024)

5.9.4 TOP APPLICANTS

FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS (2014−2024)

TABLE 9 TOP 20 PATENT OWNERS IN MARKET (2014−2024)

TABLE 10 PATENTS IN MARKET (2024)

5.10 KEY CONFERENCES & EVENTS

5.10.1 MARKET: KEY CONFERENCES & EVENTS (2024−2025)

TABLE 11 MARKET: CONFERENCES & EVENTS (2024−2025)

5.11 REGULATORY LANDSCAPE

5.11.1 REGULATORY ANALYSIS

5.11.1.1 North America

5.11.1.2 Europe

5.11.1.3 China

5.11.1.4 Japan

5.11.1.5 India

5.11.1.6 Australia

5.11.1.7 Brazil

5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 16 MARKET: REGULATORY SCENARIO

5.12 PORTER’S FIVE FORCES ANALYSIS

TABLE 17 MARKET: PORTER’S FIVE FORCES ANALYSIS

5.12.1 THREAT OF NEW ENTRANTS

5.12.2 THREAT OF SUBSTITUTES

5.12.3 BARGAINING POWER OF BUYERS

5.12.4 BARGAINING POWER OF SUPPLIERS

5.12.5 INTENSITY OF COMPETITIVE RIVALRY

5.13 KEY STAKEHOLDERS AND BUYING CRITERIA

5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MARKET

TABLE 18 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICE MODELS & SERVICES

5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS

5.13.3 BUYING CRITERIA FOR MARKET

FIGURE 27 KEY BUYING CRITERIA FOR END USERS

TABLE 19 BUYING CRITERIA FOR MICE MODEL TYPE & SERVICE, BY END USER

6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE (Page No. - 111)

6.1 INTRODUCTION

TABLE 20 MICE MODEL INDUSTRY, BY MODEL TYPE AND SERVICE, 2022–2029 (USD MILLION)

6.2 MODEL TYPES

TABLE 21 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 22 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 23 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 24 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 25 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 26 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 27 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 28 MARKET, BY TYPE, 2022–2029 (USD MILLION)

6.2.1 INBRED MICE

6.2.1.1 High utilization across research applications to propel market

TABLE 29 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 30 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 31 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 32 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 33 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 34 MIDDLE EAST: MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 35 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.2.2 GENETICALLY ENGINEERED MICE

6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market

TABLE 36 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 37 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 38 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 39 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 40 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 41 MIDDLE EAST: MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 42 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.2.3 HYBRID/CONGENIC MICE

6.2.3.1 Growing focus on biomedical research to boost demand

TABLE 43 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 44 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 45 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 46 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 47 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 48 MIDDLE EAST: MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 49 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.2.4 OUTBRED MICE

6.2.4.1 Genetic diversity benefits to support market growth

TABLE 50 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 51 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 52 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 53 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 54 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 55 MIDDLE EAST: MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 56 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3 SERVICES

TABLE 57 MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 58 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 59 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 60 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 61 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 62 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 63 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 64 MICE MODEL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

6.3.1 BREEDING SERVICES

6.3.1.1 Customization of models for specific research applications to boost demand

TABLE 65 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 66 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 67 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 68 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 69 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 70 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 71 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

6.3.2 CRYOPRESERVATION SERVICES

6.3.2.1 Rising focus on preservation of novel mice models to propel market

TABLE 72 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 73 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 74 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 75 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 76 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 77 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2022–2029 (USD MILLION)

TABLE 78 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.3 REDERIVATION SERVICES

6.3.3.1 Stringent quality assurance standards to fuel market

TABLE 79 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 80 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 81 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 82 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 83 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 84 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 85 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.4 QUARANTINE SERVICES

6.3.4.1 Rising demand for germ-free mice to support market growth

TABLE 86 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 87 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 88 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 89 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 90 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 91 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 92 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.5 OTHER SERVICES

TABLE 93 MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 94 NORTH AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 95 EUROPE: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 96 ASIA PACIFIC: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 97 LATIN AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 98 MIDDLE EAST: MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 99 GCC COUNTRIES: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7 MICE MODEL MARKET, BY TECHNOLOGY (Page No. - 147)

7.1 INTRODUCTION

TABLE 100 MICE MODEL INDUSTRY, BY TECHNOLOGY, 2022–2029 (USD MILLION)

7.2 CRISPR/CAS9

7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO BOOST DEMAND

TABLE 101 CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 102 NORTH AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 103 EUROPE: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 104 ASIA PACIFIC: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 105 LATIN AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 106 MIDDLE EAST: CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 107 GCC COUNTRIES: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7.3 MICROINJECTION

7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO PROPEL MARKET

TABLE 108 MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 109 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 110 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 111 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 112 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 113 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 114 GCC COUNTRIES: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7.4 EMBRYONIC STEM CELL INJECTION

7.4.1 RISING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO DRIVE MARKET

TABLE 115 EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 116 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 117 EUROPE: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 118 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 119 LATIN AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 120 MIDDLE EAST: EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 121 GCC COUNTRIES: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7.5 NUCLEAR TRANSFER

7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET

TABLE 122 NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 123 NORTH AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 124 EUROPE: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 125 ASIA PACIFIC: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 126 LATIN AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 127 MIDDLE EAST: NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 128 GCC COUNTRIES: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7.6 OTHER TECHNOLOGIES

TABLE 129 OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 130 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 131 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 132 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 133 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 134 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 135 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

8 MICE MODEL MARKET, BY THERAPEUTIC AREA (Page No. - 164)

8.1 INTRODUCTION

TABLE 136 MICE MODEL INDUSTRY, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

8.2 ONCOLOGY

8.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTIC DEVELOPMENT TO PROPEL MARKET

TABLE 137 MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 138 NORTH AMERICA: MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 139 EUROPE: MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 140 ASIA PACIFIC: MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 141 LATIN AMERICA: MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 142 MIDDLE EAST: MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 143 GCC COUNTRIES: MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

8.3 METABOLIC DISEASES

8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET

TABLE 144 MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 145 NORTH AMERICA: MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 146 EUROPE: MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 147 ASIA PACIFIC: MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 148 LATIN AMERICA: MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 149 MIDDLE EAST: MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 150 GCC COUNTRIES: MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

8.4 IMMUNOLOGY

8.4.1 INCREASING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET

TABLE 151 MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 152 NORTH AMERICA: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 153 EUROPE: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 154 ASIA PACIFIC: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 155 LATIN AMERICA: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 156 MIDDLE EAST: MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 157 GCC COUNTRIES: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

8.5 NEUROLOGY

8.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO SUPPORT MARKET GROWTH

TABLE 158 MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 159 NORTH AMERICA: MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 160 EUROPE: MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 161 ASIA PACIFIC: MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 162 LATIN AMERICA: MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 163 MIDDLE EAST: MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 164 GCC COUNTRIES: MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

8.6 CARDIOVASCULAR DISEASES

8.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND

TABLE 165 MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 166 NORTH AMERICA: MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 167 EUROPE: MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 168 ASIA PACIFIC: MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 169 LATIN AMERICA: MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 170 MIDDLE EAST: MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 171 GCC COUNTRIES: MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

8.7 OTHER THERAPEUTIC AREAS

TABLE 172 MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION)

TABLE 173 NORTH AMERICA: MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 174 EUROPE: MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 175 ASIA PACIFIC: MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 176 LATIN AMERICA: MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 177 MIDDLE EAST: MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION)

TABLE 178 GCC COUNTRIES: MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION)

9 MICE MODEL MARKET, BY APPLICATION (Page No. - 185)

9.1 INTRODUCTION

TABLE 179 MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

9.2 DRUG DISCOVERY & DEVELOPMENT

9.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET

TABLE 180 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)

TABLE 181 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 182 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 183 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 184 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 185 MIDDLE EAST: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 186 GCC COUNTRIES: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)

9.3 RESEARCH APPLICATIONS

9.3.1 RISING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND

TABLE 187 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 188 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 189 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 190 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 191 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 192 MIDDLE EAST: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 193 GCC COUNTRIES: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

9.4 PERSONALIZED MEDICINE

9.4.1 GROWING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO PROPEL MARKET

TABLE 194 MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2029 (USD MILLION)

TABLE 195 NORTH AMERICA: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 196 EUROPE: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 197 ASIA PACIFIC: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 198 LATIN AMERICA: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 199 MIDDLE EAST: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 200 GCC COUNTRIES: MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)

10 MICE MODEL MARKET, BY END USER (Page No. - 196)

10.1 INTRODUCTION

TABLE 201 MICE MODEL INDUSTRY, BY END USER, 2022–2029 (USD MILLION)

10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND

TABLE 202 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 203 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 204 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 205 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 206 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 207 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 208 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

10.3 ACADEMIC & RESEARCH INSTITUTES

10.3.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH

TABLE 209 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 210 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 211 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 212 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 213 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 214 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 215 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

10.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

10.4.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO PROPEL MARKET

TABLE 216 MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 217 NORTH AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 218 EUROPE: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 219 ASIA PACIFIC: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 220 LATIN AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 USD MILLION)

TABLE 221 MIDDLE EAST: MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 222 GCC COUNTRIES: MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)

11 MICE MODEL MARKET, BY REGION (Page No. - 207)

11.1 INTRODUCTION

TABLE 223 MICE MODEL INDUSTRY, BY REGION, 2022–2029 (USD MILLION)

11.2 NORTH AMERICA

11.2.1 NORTH AMERICA: RECESSION IMPACT

FIGURE 28 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT

TABLE 224 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 225 NORTH AMERICA: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 226 NORTH AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 227 NORTH AMERICA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 228 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 229 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 230 NORTH AMERICA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 231 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION

11.2.2 US

11.2.2.1 Rising production of monoclonal antibodies to fuel market for mice models

TABLE 232 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 233 US: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 234 US: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 235 US: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 236 US: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 237 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 238 US: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.2.3 CANADA

11.2.3.1 Growth in stem cell research activities to support market growth

TABLE 239 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 240 CANADA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 241 CANADA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 242 CANADA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 243 CANADA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 244 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 245 CANADA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.3 EUROPE

11.3.1 EUROPE: RECESSION IMPACT

TABLE 246 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 247 EUROPE: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 248 EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 249 EUROPE: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 250 EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 251 EUROPE: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 252 EUROPE: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 253 EUROPE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.2 GERMANY

11.3.2.1 Growing biotechnology industry to drive market

TABLE 254 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 255 GERMANY: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 256 GERMANY: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 257 GERMANY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 258 GERMANY: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 259 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 260 GERMANY: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.3 UK

11.3.3.1 Increasing focus on cancer research to propel market

TABLE 261 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 262 UK: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 263 UK: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 264 UK: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 265 UK: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 266 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 267 UK: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.4 FRANCE

11.3.4.1 Increased investments in proteomics and genomics to fuel growth

TABLE 268 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 269 FRANCE: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 270 FRANCE: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 271 FRANCE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 272 FRANCE: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 273 FRANCE: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 274 FRANCE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.5 ITALY

11.3.5.1 Growth in pharmaceutical and biotechnology industry to drive market

TABLE 275 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 276 ITALY: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 277 ITALY: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 278 ITALY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 279 ITALY: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 280 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 281 ITALY: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.6 SPAIN

11.3.6.1 Extensive R&D pipeline to support market growth

TABLE 282 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 283 SPAIN: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 284 SPAIN: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 285 SPAIN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 286 SPAIN: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 287 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 288 SPAIN: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.3.7 REST OF EUROPE

TABLE 289 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 290 REST OF EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 291 REST OF EUROPE: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 292 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 293 REST OF EUROPE: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 294 REST OF EUROPE: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 295 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4 ASIA PACIFIC

11.4.1 ASIA PACIFIC: RECESSION IMPACT

FIGURE 29 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT

TABLE 296 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 297 ASIA PACIFIC: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 298 ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 299 ASIA PACIFIC: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 300 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 301 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 302 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 303 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.2 CHINA

11.4.2.1 Growing funding and investments in life sciences research to drive market

TABLE 304 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 305 CHINA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 306 CHINA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 307 CHINA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 308 CHINA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 309 CHINA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 310 CHINA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.3 JAPAN

11.4.3.1 Increasing focus on personalized diagnostics products to drive market

TABLE 311 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 312 JAPAN: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 313 JAPAN: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 314 JAPAN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 315 JAPAN: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 316 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 317 JAPAN: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.4 INDIA

11.4.4.1 Increasing initiatives for drug discovery to boost market growth

TABLE 318 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 319 INDIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 320 INDIA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 321 INDIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 322 INDIA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 323 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 324 INDIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.5 AUSTRALIA

11.4.5.1 High number of research institutes to favor market growth

TABLE 325 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 326 AUSTRALIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 327 AUSTRALIA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 328 AUSTRALIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 329 AUSTRALIA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 330 AUSTRALIA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 331 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.6 SOUTH KOREA

11.4.6.1 Rising R&D investments in drug development to fuel uptake of genetically engineered mice models

TABLE 332 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 333 SOUTH KOREA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 334 SOUTH KOREA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 335 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 336 SOUTH KOREA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 337 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 338 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.4.7 REST OF ASIA PACIFIC

TABLE 339 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 340 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 341 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 342 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 343 REST OF ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 344 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 345 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.5 LATIN AMERICA

11.5.1 LATIN AMERICA: RECESSION IMPACT

TABLE 346 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 347 LATIN AMERICA: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 348 LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 349 LATIN AMERICA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 350 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 351 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 352 LATIN AMERICA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 353 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.5.2 BRAZIL

11.5.2.1 Increasing Investments in Biopharmaceutical research to propel market growth

TABLE 354 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 355 BRAZIL: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 356 BRAZIL: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 357 BRAZIL: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 358 BRAZIL: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 359 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 360 BRAZIL: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.5.3 MEXICO

11.5.3.1 Expanding healthcare ecosystem to support market growth

TABLE 361 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 362 MEXICO: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 363 MEXICO: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 364 MEXICO: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 365 MEXICO: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 366 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 367 MEXICO: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.5.4 REST OF LATIN AMERICA

TABLE 368 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 369 REST OF LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 370 REST OF LATIN AMERICA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 371 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 372 REST OF LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 373 REST OF LATIN AMERICA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 374 REST OF LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.6 MIDDLE EAST

11.6.1 MIDDLE EAST: RECESSION IMPACT

TABLE 375 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 376 MIDDLE EAST: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 377 MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 378 MIDDLE EAST: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 379 MIDDLE EAST: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 380 MIDDLE EAST: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 381 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 382 MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.6.2 GCC COUNTRIES

TABLE 383 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 384 GCC COUNTRIES: MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 385 GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 386 GCC COUNTRIES: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 387 GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 388 GCC COUNTRIES: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 389 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 390 GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.6.2.1 SAUDI ARABIA

11.6.2.1.1 Growing focus on advancement of healthcare sector to boost market growth

TABLE 391 SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 392 SAUDI ARABIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 393 SAUDI ARABIA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 394 SAUDI ARABIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 395 SAUDI ARABIA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 396 SAUDI ARABIA: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 397 SAUDI ARABIA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION)

11.6.2.2 UNITED ARAB EMIRATES

11.6.2.2.1 Increasing R&D activities and growing demand for personalized medicine to propel market

TABLE 398 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 399 UNITED ARAB EMIRATES: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 400 UNITED ARAB EMIRATES: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 401 UNITED ARAB EMIRATES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 402 UNITED ARAB EMIRATES: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 403 UNITED ARAB EMIRATES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 404 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.6.2.3 REST OF GCC COUNTRIES

TABLE 405 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 406 REST OF GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 407 REST OF GCC COUNTRIES: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 408 REST OF GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 409 REST OF GCC COUNTRIES: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 410 REST OF GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 411 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.6.3 REST OF MIDDLE EAST

TABLE 412 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 413 REST OF MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 414 REST OF MIDDLE EAST: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 415 REST OF MIDDLE EAST: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 416 REST OF MIDDLE EAST: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 417 REST OF MIDDLE EAST: MICE MODEL INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 418 REST OF MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

11.7 AFRICA

11.7.1 GROWING PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH

11.7.2 AFRICA: RECESSION IMPACT

TABLE 419 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION)

TABLE 420 AFRICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 421 AFRICA: MARKET, BY SERVICE, 2022–2029 (USD MILLION)

TABLE 422 AFRICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)

TABLE 423 AFRICA: MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION)

TABLE 424 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 425 AFRICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION

12 COMPETITIVE LANDSCAPE (Page No. - 294)

12.1 OVERVIEW

12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN

TABLE 426 KEY PLAYERS STRATEGIES IN MICE MODEL MARKET, 2021−2024

12.3 REVENUE SHARE ANALYSIS

FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2019–2023 (USD MILLION)

12.4 MARKET SHARE ANALYSIS

FIGURE 31 MICE MODEL INDUSTRY SHARE ANALYSIS OF KEY PLAYERS (2023)

TABLE 427 MICE MODEL INDUSTRY: INTENSITY OF COMPETITIVE RIVALRY

12.5 FINANCIAL METRICS

12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS

12.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL

FIGURE 32 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL

12.6.1.1 CHARLES RIVER LABORATORIES

12.6.1.2 THE JACKSON LABORATORY

12.6.1.3 INOTIV

12.6.1.4 TACONIC BIOSCIENCES, INC.

12.6.1.5 BIOCYTOGEN

12.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE

FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE

12.6.2.1 CHARLES RIVER LABORATORIES

12.6.2.2 THE JACKSON LABORATORY

12.6.2.3 INOTIV

12.6.2.4 TACONIC BIOSCIENCES, INC.

12.6.2.5 BIOCYTOGEN

12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS (2023)

12.7.1 STARS

12.7.2 EMERGING LEADERS

12.7.3 PERVASIVE PLAYERS

12.7.4 PARTICIPANTS

FIGURE 34 MICE MODEL INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2023,

12.7.5 COMPANY FOOTPRINT (KEY PLAYERS)

FIGURE 35 MICE MODEL INDUSTRY: COMPANY FOOTPRINT KEY PLAYERS

TABLE 428 INDUSTRY FOOTPRINT (KEY PLAYERS)

12.7.6 PRODUCT & SERVICE FOOTPRINT

TABLE 429 MICE MODEL INDUSTRY: PRODUCT & SERVICE FOOTPRINT (KEY PLAYERS)

12.7.7 REGIONAL FOOTPRINT (KEY PLAYERS)

TABLE 430 REGIONAL FOOTPRINT (KEY PLAYERS)

12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES

12.8.1 PROGRESSIVE COMPANIES

12.8.2 RESPONSIVE COMPANIES

12.8.3 DYNAMIC COMPANIES

12.8.4 STARTING BLOCKS

FIGURE 36 MICE MODEL INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023

12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES

TABLE 431 MICE MODEL INDUSTRY: KEY STARTUPS/SMES

TABLE 432 MICE MODEL INDUSTRY: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES

12.9 COMPETITIVE SCENARIO

12.9.1 PRODUCT LAUNCHES

TABLE 433 MICE MODEL INDUSTRY: PRODUCT LAUNCHES, JANUARY 2021−JANUARY 2024

12.9.2 DEALS

TABLE 434 MICE MODEL INDUSTRY: DEALS, JANUARY 2021−JANUARY 2024

12.9.3 EXPANSIONS

TABLE 435 MICE MODEL INDUSTRY: EXPANSIONS, JANUARY 2021−JANUARY 2024

13 COMPANY PROFILES (Page No. - 313)

13.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

13.1.1 CHARLES RIVER LABORATORIES

TABLE 436 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW

FIGURE 37 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)

TABLE 437 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED

TABLE 438 CHARLES RIVER LABORATORIES: DEALS

TABLE 439 CHARLES RIVER LABORATORIES: EXPANSIONS

13.1.2 INOTIV

TABLE 440 INOTIV: BUSINESS OVERVIEW

TABLE 441 INOTIV: PRODUCTS/SERVICES OFFERED

TABLE 442 INOTIV: PRODUCT LAUNCHES

TABLE 443 INOTIV: DEALS

TABLE 444 INOTIV: EXPANSIONS

13.1.3 THE JACKSON LABORATORY

TABLE 445 THE JACKSON LABORATORY: BUSINESS OVERVIEW

TABLE 446 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED

TABLE 447 THE JACKSON LABORATORY: PRODUCT LAUNCHES

TABLE 448 THE JACKSON LABORATORY: DEALS

13.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC.

TABLE 449 SHANGHAI MODEL ORGANISMS CENTER, INC.: BUSINESS OVERVIEW

FIGURE 40 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2022)

TABLE 450 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED

13.1.5 JSR CORPORATION

TABLE 451 JSR CORPORATION: BUSINESS OVERVIEW

FIGURE 41 JSR CORPORATION: COMPANY SNAPSHOT (2022)

TABLE 452 JSR CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 453 JSR CORPORATION: DEALS

13.1.6 BIOCYTOGEN

TABLE 454 BIOCYTOGEN: BUSINESS OVERVIEW

FIGURE 42 BIOCYTOGEN: COMPANY SNAPSHOT (2022)

TABLE 455 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED

TABLE 456 BIOCYTOGEN: PRODUCT LAUNCHES

TABLE 457 BIOCYTOGEN: DEALS

TABLE 458 BIOCYTOGEN: EXPANSIONS

13.1.7 TRANS GENIC INC.

TABLE 459 TRANS GENIC INC.: BUSINESS OVERVIEW

FIGURE 43 TRANS GENIC INC.: COMPANY SNAPSHOT (2023)

TABLE 460 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED

13.1.8 HARBOUR BIOMED

TABLE 461 HARBOUR BIOMED: BUSINESS OVERVIEW

FIGURE 44 HARBOUR BIOMED: COMPANY SNAPSHOT (2022)

TABLE 462 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED

TABLE 463 HARBOUR BIOMED: OTHER DEVELOPMENTS

13.1.9 GENOWAY

TABLE 464 GENOWAY: BUSINESS OVERVIEW

FIGURE 45 GENOWAY: COMPANY SNAPSHOT (2022)

TABLE 465 GENOWAY: PRODUCTS/SERVICES OFFERED

TABLE 466 GENOWAY: DEALS

13.1.10 GEMPHARMATECH

TABLE 467 GEMPHARMATECH: BUSINESS OVERVIEW

TABLE 468 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED

TABLE 469 GEMPHARMATECH: DEALS

TABLE 470 GEMPHARMATECH: EXPANSIONS

13.1.11 CYAGEN

TABLE 471 CYAGEN: BUSINESS OVERVIEW

TABLE 472 CYAGEN: PRODUCTS/SERVICES OFFERED

13.1.12 OZGENE PTY LTD.

TABLE 473 OZGENE PTY LTD.: BUSINESS OVERVIEW

TABLE 474 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED

TABLE 475 DEALS

13.1.13 TACONIC BIOSCIENCES, INC.

TABLE 476 TACONIC BIOSCIENCES, INC.: BUSINESS OVERVIEW

TABLE 477 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED

TABLE 478 TACONIC BIOSCIENCES, INC.: PRODUCT LAUNCHES

TABLE 479 TACONIC BIOSCIENCES, INC.: DEALS

13.1.14 TRANSCURE BIOSERVICES

TABLE 480 TRANSCURE BIOSERVICES: BUSINESS OVERVIEW

TABLE 481 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED

13.1.15 MARSHALL BIORESOURCES

TABLE 482 MARSHALL BIORESOURCES: BUSINESS OVERVIEW

TABLE 483 MARSHALL BIORESOURCES: PRODUCTS/SERVICES OFFERED

13.1.16 VIVO BIO TECH LTD.

TABLE 484 VIVO BIO TECH LTD.: BUSINESS OVERVIEW

FIGURE 46 VIVO BIO TECH LTD: COMPANY SNAPSHOT (2022)

TABLE 485 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED

13.1.17 INGENIOUS TARGETING LABORATORY

TABLE 486 INGENIOUS TARGETING LABORATORY: BUSINESS OVERVIEW

TABLE 487 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED

13.1.18 JANVIER LABS

TABLE 488 JANVIER LABS: BUSINESS OVERVIEW

TABLE 489 JANVIER LABS: PRODUCTS/SERVICES OFFERED

13.2 OTHER PLAYERS

13.2.1 APPLIED STEMCELL

TABLE 490 APPLIED STEMCELL: BUSINESS OVERVIEW

13.2.2 CREATIVE ANIMODEL

TABLE 491 CREATIVE ANIMODEL: BUSINESS OVERVIEW

13.2.3 JOINN LABORATORIES (CHINA) CO., LTD.

TABLE 492 JOINN LABORATORIES (CHINA) CO., LTD.: BUSINESS OVERVIEW

13.2.4 CREATIVE BIOLABS

TABLE 493 CREATIVE BIOLABS: BUSINESS OVERVIEW

13.2.5 CRESCENDO BIOLOGICS

TABLE 494 CRESCENDO BIOLOGICS: BUSINESS OVERVIEW

13.2.6 ARAGEN LIFE SCIENCES

TABLE 495 ARAGEN LIFE SCIENCES: BUSINESS OVERVIEW

13.2.7 POLYGENE

TABLE 496 POLYGENE: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 379)

14.1 DISCUSSION GUIDE

14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

14.3 CUSTOMIZATION OPTIONS

14.4 RELATED REPORTS

14.5 AUTHOR DETAILS

Mice Model Market - Global Forecast to 2029

by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery)

Table of Content

How can I help you?

Purchase this report

This report can be of interest as well:

Mice Model - Global Forecast 2024-2030

Mark your calendar:

Clinical Trial Supply Forum 2024

Clinical Services, Trials & Research Market Research

Mice Model Market - Global Forecast to 2029

by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery)

Table of Content

How can I help you?

Purchase this report

This report can be of interest as well:

Mice Model - Global Forecast 2024-2030

Mark your calendar:

Clinical Trial Supply Forum 2024